Pregled bibliografske jedinice broj: 1260447
In Hydronephrosis‐Rats, BPC 157 Exerts a Strong Anti‐Ulcer Effect in Both Stomach and Duodenum along with Marked Kidney Recovery
In Hydronephrosis‐Rats, BPC 157 Exerts a Strong Anti‐Ulcer Effect in Both Stomach and Duodenum along with Marked Kidney Recovery // FASEB Journal
San Diego (CA), Sjedinjene Američke Države: John Wiley & Sons, 2020. str. 1-1 doi:10.1096/fasebj.2020.34.s1.03972 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1260447 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
In Hydronephrosis‐Rats, BPC 157 Exerts a Strong
Anti‐Ulcer Effect in Both Stomach and Duodenum
along with Marked Kidney Recovery
Autori
Vranes, Hrvoje ; Krezic, Ivan ; Gojkovic, Slaven ; Zizek, Helena ; Durasin, Tajana ; Petrovic, Andrea ; Pavlov, Katarina Horvat ; Batelja, Lovorka ; Blagaic, Alenka Boban ; Seiwerth, Sven ; Sikiric, Predrag
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
FASEB Journal
/ - : John Wiley & Sons, 2020, 1-1
Skup
Experimental Biology
Mjesto i datum
San Diego (CA), Sjedinjene Američke Države, 04.04.2020. - 07.04.2020
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
BPC 157 ; cytoprotection ; hydronephrosis ; stomach ulcer
Sažetak
Background/Hypothesis We focused on the anti-ulcerogenic potential of the stable gastric pentadecapeptide BPC 157 in rats used to have unilateral ureter obstruction. Prolonged unilateral ureter obstruction (UUO) after obstruction removal in addition to renal injury, may produce significant stomach and duodenal lesions in rats. Previously, BPC 157 markedly counteracted gastric lesions in nephrectomized rats (FASEB J 2016 ; 30: 1 Suppl:720.2 ; FASEB J 2015 ; 29: 1:628.10). Methods Rats had ureteral ligation for 72 hours, and thereby, hydronephrosis, fibrosis development, tubular cell damage, and interstitial inflammation. Then, at 5 min after the ureter was obstruction was removed, we applied medication (stable gastric pentadecapeptide BPC 157 (10 μg/kg ; 10 ng/kg) or saline) given as an intraperitoneal bath (1mL bath/rat). Assessment was at 24 h and 96 h after medication and included renal lesions (0- healthy kidney, 1- mild hydronephrosis, 2- moderate hydronephrosis, visible dilation of renal pelvis, few lesions on kidney surface, 3- severe hydronephrosis, dilatation of renal pelvis, thinning of the renal parenchyma and considerable number of lesions on the kidney surface), gastric and duodenal lesions (sum of the longest diameters, mm), urea, creatinine, AST, ALT, bilirubin, K, Na, Mg, Ca, inorganic phosphates in serum, as described (Sikiric et al, Curr Pharm Des. 2014 ; 20(7):1126– 35). Results BPC 157 medication results in marked and advanced improvement, seen at 24 h and 96 h thereafter. For illustration, regular severe hydronephrosis, dilatation of renal pelvis, thinning of the renal parenchyma was reversed to only mild or no hydronephrosis. Likewise, both gastric and duodenal lesions, that regularly appear as quite severe hemorrhagic lesions (gastric 12±1 ; duodenal 9±2 at 24h), were markedly reduced, or completely eliminated after BPC 157 medication, either 10 μg or 10 ng regimen (stomach 1±1 ; duodenal 1±1 at 24 h, 10 ng-regimen). Conclusions In hydronephrosis-rats, BPC 157 exerts a strong anti-ulcer effect in both stomach and duodenum along with marked kidney recovery.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-108-1083570-3635 - Pentadekapeptid BPC 157 - daljnja istraživanja (Sikirić, Predrag, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Ivan Krezić
(autor)
Helena Žižek
(autor)
Predrag Sikirić
(autor)
Sven Seiwerth
(autor)
Lovorka Batelja Vuletić
(autor)
Slaven Gojković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE